Skip to main content
. 2021 Mar 5;13(3):420. doi: 10.3390/v13030420

Table 1.

Agreement between GeneFinder RT-qPCR and Lyo-CRISPR SARS-CoV-2 kit results for testing samples extracted with spin column (n = 210) and samples in lysis buffer (n = 30) from hospitalized patients.

Respiratory Samples GeneFinder RT-qPCR Lyo-CRISPR SARS-CoV-2 Agreement Overall Agreement Cohen Kappa
E Gene N Gene RdRp Gene Negative Positive
RT-qPCR result Ct mean (range) Ct mean (range) Ct mean (range) n n % (95%CI) % (95%CI) k (95%CI)
RNA extracted
Negative (n = 105) - - - 104 1 99.05 (94.81–99.97) 99.52 (97.38–99.99) 0.991 (0.972–1)
Positive (n = 105) 25.65 (10.83–40.02) 24.19 (11.45–36.90) 24.03 (11.36–34.27) 0 105 100 (96.55–100)
Lysis Buffer
Negative (n = 9) - - - 9 0 100 (66.37–100) 96.67 (82.78–99.92) 0.923 (0.775–1)
Positive (n = 21) 21.33 (9.10–35.60) 22.58 (9.17–36.65) 19.57 (8.30–34.32) 1 20 95.24 (76.18–99.88)

Lyo: lyophilized; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; CRISPR: clustered regularly interspaced short palindromic repeats; 95%CI: 95% confidence interval; Ct: cycle threshold.